Dividend Logo Green Small
MENU
Advertisement.

GNLX:Genelux Corp - Stock Price Quote and Dividend Data

GNLX STOCK PRICE LATEST CLOSE

$2.08

EXCHANGE

NASDAQ

GNLX

Genelux Corp Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
GNLX

Genelux Corp Stock Price Information

GNLX Stock Price Latest Close$2.08
52-Week Low/High Stock Price$1.60 - $5.89
Percent Held by Institutions19.12%
Revenue$8,000
Net Income$-38,845,000
Cash Flow$-25,530,000
EPS-0.26%
Market Cap$71,976,320
PE Ratio0
PE Ratio to Industry114%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-55.46%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 08, 2025
GNLX

Genelux Corp Annual Stock Dividends

No Data available for Payment History.

GNLX

Genelux Corp Dividend Payment History

No dividends retrieved for GNLX
GNLX

Genelux Corp Other Dividend Details

Genelux Corporation is a late clinical-stage biopharmaceutical company. Co. is focused on developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its clinical and preclinical product candidates are intended to selectively kill tumor cells and induce a robust immune response against a patient's tumor neoantigens. Its product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified strain of the vaccinia virus (VACV), a stable deoxyribonucleic acid (DNA) virus with a large engineering capacity.

Web Sitewww.genelux.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Genelux Corp Dividend Stock News and Updates

Apr. 01, 2025GNLX STOCK PRICE DECREASE: Genelux Corp on 04-01-2025 decreased stock price > 10% from $3.08 to $2.70

Mar. 26, 2025GNLX STOCK PRICE DECREASE: Genelux Corp on 03-26-2025 decreased stock price > 10% from $3.89 to $3.40

Mar. 08, 2025GNLX STOCK PRICE INCREASE: Genelux Corp on 03-08-2025 increased stock price > 10% from $3.73 to $4.20

Mar. 04, 2025GNLX STOCK PRICE DECREASE: Genelux Corp on 03-04-2025 decreased stock price > 10% from $4.18 to $3.65

Feb. 20, 2025GNLX STOCK PRICE INCREASE: Genelux Corp on 02-20-2025 increased stock price > 10% from $4.74 to $5.23

Feb. 19, 2025GNLX STOCK PRICE DECREASE: Genelux Corp on 02-19-2025 decreased stock price > 10% from $5.34 to $4.74

Feb. 12, 2025GNLX STOCK PRICE INCREASE: Genelux Corp on 02-12-2025 increased stock price > 10% from $4.57 to $5.66

Feb. 05, 2025GNLX STOCK PRICE INCREASE: Genelux Corp on 02-05-2025 increased stock price > 10% from $3.53 to $3.90

Feb. 04, 2025GNLX STOCK PRICE DECREASE: Genelux Corp on 02-04-2025 decreased stock price > 10% from $3.95 to $3.53

Jan. 25, 2025GNLX STOCK PRICE INCREASE: Genelux Corp on 01-25-2025 increased stock price > 10% from $3.36 to $3.96

More Genelux Corp Dividend News
Biotechnology Dividend Stock News and Updates

Apr. 09, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-09-2025 decreased stock price > 10% from $0.40 to $0.27

Apr. 09, 2025MAZE STOCK PRICE DECREASE: Maze Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $8.92 to $7.57

Apr. 09, 2025KANT STOCK PRICE DECREASE: Kineta Inc on 04-09-2025 decreased stock price > 10% from $0.35 to $0.30

Apr. 09, 2025ORKA STOCK PRICE DECREASE: Oruka Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $7.62 to $6.78

Apr. 09, 2025XCUR STOCK PRICE DECREASE: Com Par $0.0001/Exicure Inc on 04-09-2025 decreased stock price > 10% from $12.80 to $11.39

Apr. 09, 2025BIVI STOCK PRICE DECREASE: Cl A Par $0.0001/BioVie Inc on 04-09-2025 decreased stock price > 10% from $0.80 to $0.71

Apr. 09, 2025ARTV STOCK PRICE DECREASE: Artiva Biotherapeutics Inc on 04-09-2025 decreased stock price > 10% from $3.31 to $1.92

Apr. 09, 2025ENTO STOCK PRICE DECREASE: Com Par $0.0001 (New)/Entero Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.49 to $0.42

Apr. 09, 2025APDN STOCK PRICE DECREASE: Com Par $0.001 (New)/Applied DNA Sciences Inc on 04-09-2025 decreased stock price > 10% from $1.30 to $1.13

Apr. 09, 2025RKVTF STOCK PRICE DECREASE: Rakovina Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.06 to $0.05

More Biotechnology Dividend News
X
Search Dividend Investor